Bristol Myers Squibb logo

Director, Global Pricing and Market Access Strategy Lead - Immunology

Bristol Myers Squibb

Princeton, NJHybridPosted 2 days ago$196,390 - $237,982
Full TimeDirector & AboveCommercial & Pharma SalesPharmaceutical
Original posting ↗

Summary

Lead the global pricing and market access strategy for admilparant, a potential first-in-class treatment for IPF and PPF, across international markets. Reporting to the Executive Director, GMAx Global Launch Strategy for Cardiovascular and Immunology, this role brings an integrated Market Access perspective to key development and commercialization decisions as the Market Access representative on the Global Product Team.

Job description

Responsibilities

  • Lead the integrated Global Market Access strategy for admilparant, partnering with HEOR to develop differentiated payer value propositions across clinical, humanistic and economic dimensions.
  • Shape the evidence-generation strategy, ensuring interventional, non-interventional and real-world evidence addresses the needs of payers, HTA bodies and other access decision-makers.
  • Bring a strong Market Access perspective to the Global Product Team, influencing development and commercialization decisions and ensuring clinical trial designs, endpoints and evidence plans support future access and reimbursement.
  • Partner with HEOR and Regulatory to identify opportunities for an optimal product label and patient-reported outcome claims that strengthen the payer value proposition.
  • Translate pricing, reimbursement, policy and competitive developments into clear strategic implications for admilparant.
  • Embed access and pricing considerations into global brand and commercialization strategy, reflecting payer and HTA requirements across key geographies.
  • Lead the Global Market Access Core Value Team for admilparant, creating alignment across functions and markets on strategy, priorities and execution.
  • Drive delivery of critical Market Access projects and milestones, aligning cross-functional partners and ensuring launch readiness and access success.
  • Contribute actively to Market Access and pricing governance, bringing clear recommendations and helping senior stakeholders navigate complex strategic trade-offs.

Qualifications

  • An undergraduate degree; an MBA, MPH, MSc, PhD or other relevant advanced degree is preferred but not required.
  • Significant experience in global market access, pricing, reimbursement and/or HEOR within the pharmaceutical or biotechnology industry, ideally including responsibility for global strategy.
  • Strong knowledge of the global access environment and ability to translate evolving payer, HTA, pricing, reimbursement and policy developments into clear implications for product strategy.
  • Experience shaping access strategy for assets in development or preparing for launch.
  • Experience in immunology, respiratory disease, pulmonary fibrosis or another specialty area would be an advantage, but is not essential.
  • Strong understanding of pharmaceutical development and commercialization, including assessing clinical trial designs, endpoints and evidence plans from a payer and HTA perspective.
  • Experience developing payer value propositions and evidence strategies that integrate clinical, humanistic and economic value.
  • Strong strategic judgement and business and financial acumen, with ability to synthesize complex evidence and differing perspectives into clear recommendations.
  • Demonstrated ability to communicate complex access issues clearly and credibly to senior leaders and cross-functional stakeholders.
  • A record of leading through influence in a global matrix, building alignment across functions and markets.
  • Proven ability to prioritize and deliver multiple complex projects in a fast-moving environment, including ambiguity or incomplete information.
  • An inclusive and collaborative leadership style with cultural awareness to work across countries, functions and perspectives.
  • Ability to travel internationally for congresses, market engagements and internal meetings, as required.

Requirements

  • An undergraduate degree
  • MBA, MPH, MSc, PhD or other relevant advanced degree preferred but not required
  • Significant experience in global market access, pricing, reimbursement and/or HEOR within pharmaceutical or biotechnology industry
  • Ideally including responsibility for global strategy
  • Strong knowledge of the global access environment
  • Ability to translate payer, HTA, pricing, reimbursement and policy developments into product strategy implications
  • Experience shaping access strategy for assets in development or preparing for launch
  • Experience in immunology, respiratory disease, pulmonary fibrosis or another specialty area an advantage but not essential
  • Strong understanding of pharmaceutical development and commercialization
  • Ability to assess clinical trial designs, endpoints and evidence plans from a payer and HTA perspective
  • Experience developing payer value propositions and evidence strategies integrating clinical, humanistic and economic value
  • Strong strategic judgement and business and financial acumen
  • Demonstrated ability to communicate complex access issues to senior leaders and cross-functional stakeholders
  • Record of leading through influence in a global matrix
  • Proven ability to prioritize and deliver multiple complex projects in a fast-moving environment
  • Inclusive and collaborative leadership style with cultural awareness
  • Ability to travel internationally as required

Benefits

  • Medical, Dental & Vision
  • Life & Disability Insurance
  • Retirement Benefits
  • Flexible Time Off
  • 11 Paid Holidays
  • Paid Sick Leave
  • Volunteer Days
  • Summer Hours Flexibility
  • Global Shutdown
  • Wellbeing Support
  • Incentive Cash & Stock

Company overview

Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.